天眼查商业履历信息显示，无锡航亚科技股份有限公司，成立于2013年，位于无锡市，是一家以从事软 件和信息技术服务业为主的企业。企业注册资本25838.2608万人民币，实缴资本13578.2608万人民币。 公司法定代表人为严奇。 通过天眼查大数据分析，无锡航亚科技股份有限公司共对外投资了3家企业，参与招投标项目73次，知 识产权方面有商标信息7条，专利信息168条，此外企业还拥有行政许可51个。 8月25日，沪深两融数据显示，航亚科技上周累计获融资净买入额2495.29万元，居两市第479位，上周 融资买入额1.71亿元，偿还额1.46亿元。 航亚科技所属概念板块包括：航天航空、江苏板块、专精特新、融资融券、大飞机、医疗器械概念、通 用航空。 资金流方面，航亚科技近5日主力资金流出4268.25万元，区间跌幅3.58%；近10日主力资金流出5426.08 万元，区间跌幅2.21%。 来源：金融界 ...

Group 1 - The stock price of Huayang Intelligent on August 20 was 59.99 yuan, down 4.88 yuan or 7.52% from the previous trading day [1] - The opening price on that day was 64.50 yuan, with a highest price of 64.50 yuan and a lowest price of 57.31 yuan, with a trading volume of 57,448 hands and a transaction amount of 343 million yuan [1] - At 9:38 AM on August 20, Huayang Intelligent's stock price experienced a quick rebound, increasing over 2% within 5 minutes, reaching a price of 61.57 yuan with a transaction amount of 58.18 million yuan [1] Group 2 - Huayang Intelligent's main business includes the research, production, and sales of micro motors and intelligent control systems, with applications in smart home and medical device sectors [1] - The company operates in sectors including motors, smart home, and medical device concepts [1] Group 3 - On August 20, the net outflow of main funds for Huayang Intelligent was 21.02 million yuan, accounting for 1.44% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 4.26 million yuan, representing 0.29% of the circulating market value [1]

Market Overview - The market experienced narrow fluctuations in the early session, with the three major indices showing slight increases [1][2] - The half-day trading volume in the Shanghai and Shenzhen markets reached 1.08 trillion, a decrease of 111.9 billion compared to the previous trading day [1][2] - Overall, more than 2900 stocks declined, indicating a mixed performance across individual stocks [1][2] Sector Performance - The super hydropower concept stocks rebounded, with Shanhe Intelligent hitting the daily limit [1][2] - Commercial aerospace concept stocks saw a brief surge, with Shanghai Huguang also reaching the daily limit [1][2] - Medical device concept stocks remained active, with Shangrong Medical hitting the daily limit [1][2] - In contrast, AI application stocks collectively adjusted, with Jinxiandai dropping over 10% [1][2] Index Performance - By the end of the trading session, the Shanghai Composite Index rose by 0.07%, the Shenzhen Component Index increased by 0.14%, and the ChiNext Index gained 0.21% [1][2]

Core Viewpoint - The medical device industry experienced a slight increase of 0.47% on July 28, with a net outflow of funds amounting to 295 million [1] Group 1: Market Performance - A total of 52 stocks in the sector rose, while 68 stocks declined [1] - The top-performing stocks included: - Aidi Te (16.88%) - Kehua Bio (10.01%) - Rejing Bio (6.88%) - Zhengchuan Co. (6.68%) - David Medical (6.55%) [1][1][1] Group 2: Fund Flow - The net capital flow for the top gainers was as follows: - Aidi Te: 106 million - Kehua Bio: 12 million - Rejing Bio: 21 million - Zhengchuan Co.: -14 million (outflow) [1][1][1] - Other notable stocks with positive fund flow included: - David Medical: -6 million (outflow) - Sainuo Medical: 6 million [1][1] Group 3: Declining Stocks - The stocks with the largest declines included: - Aohua Endoscopy (-4.09%) - Tianyi Medical (-2.73%) - Mountain Outside Mountain (-2.53%) - Ruimaite (-2.42%) - Jianfan Bio (-2.32%) [1][1][1] - Additional stocks that saw declines were: - Lude Medical (-2.22%) - Nanwei Medical (-2.14%) - San Nuo Bio (-2.13%) [1][1]

Group 1 - The stock of Sanyou Medical (688085) has a comprehensive score of 43.15, indicating a weak performance [1] - The main cost analysis shows that the current main cost is 18.74 yuan, with a 5-day main cost of 18.44 yuan and a 20-day main cost of 19.31 yuan [1] - There have been no instances of the stock hitting the upper limit in the past year, and it has also not hit the lower limit [1] Group 2 - The short-term pressure level is at 18.73 yuan, while the short-term support level is at 18.05 yuan [2] - The stock price has broken through the short-term pressure level, indicating a potential short-term strength, although the medium-term trend remains unclear [2] - The funds flow data for June 25, 2025, shows a net outflow of 17.43 million yuan from main funds, with retail investors experiencing a net outflow of 4.39 million yuan [2]

板块跌幅居前的股票包括：热景生物（-5.39%）、浩欧博（-4.67%）、科华生物（-4.25%）、惠泰医疗 （-2.79%）、大博医疗（-2.04%）、昊海生科（-1.63%）、奕瑞科技（-1.43%）、康拓医疗 （-1.4%）、华兰股份（-1.25%）、微电生理（-0.93%）、华大智造（-0.61%）、诺唯赞（-0.5%）、基 蛋生物（-0.5%）、佰仁医疗（-0.22%）、利德曼（-0.21%）、赛诺医疗（-0.2%）、山东药玻 （-0.18%）、天臣医疗（-0.18%）、博晖创新（-0.17%）、爱博医疗（-0.03%） 来源：金融界 5月12日，截至收盘，医疗器械行业上涨1.19%，板块资金流入1.72亿。上涨个股家数98个，下跌个股家 数20个。 板块涨幅居前的十大牛股分别是：尚荣医疗（10.0%）、鹿得医疗（7.78%）、开立医疗（6.88%）、爱 朋医疗（5.45%）、硕世生物（5.0%）、华大基因（4.97%）、山外山（4.61%）、中红医疗 （3.95%）、采纳股份（3.78%）、辰光医疗（3.57%）、博拓生物（3.55%）、万孚生物（3.33%）、奥 精医疗（3.29%）、美好医疗（ ...